At the end of the latest market close, CollPlant Biotechnologies Ltd. (CLGN) was valued at $24.25. In that particular session, Stock kicked-off at the price of $23.24 while reaching the peak value of $24.26 and lowest value recorded on the day was $23.1533. The stock current value is $17.07.
Recently in News on February 12, 2021, CollPlant Announces $35.0 Million Registered Direct Offering of American Depositary Shares. CollPlant Biotechnologies (NASDAQ:CLGN), today announced that it has entered into definitive agreements with several healthcare-focused and other institutional investors for the purchase and sale of 2,000,000 of the Company’s American Depositary Shares (ADSs), at a purchase price of $17.50 per ADS, in a registered direct offering. Each ADS represents one (1) ordinary share, par value NIS 1.50 per share, of CollPlant. The offering is expected to close on or about February 17, 2021, subject to satisfaction of customary closing conditions. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
CollPlant Biotechnologies Ltd. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $24.26 on 02/11/21, with the lowest value was $10.25 for the same time period, recorded on 01/04/21.
CollPlant Biotechnologies Ltd. (CLGN) full year performance was 119.26%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, CollPlant Biotechnologies Ltd. shares are logging -29.66% during the 52-week period from high price, and 184.42% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $6.00 and $24.26.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 672259 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the CollPlant Biotechnologies Ltd. (CLGN) recorded performance in the market was 125.16%, having the revenues showcasing 258.73% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 161.02M, as it employees total of 38 workers.
The Analysts eye on CollPlant Biotechnologies Ltd. (CLGN)
During the last month, 0 analysts gave the CollPlant Biotechnologies Ltd. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 10.43, with a change in the price was noted +8.95. In a similar fashion, CollPlant Biotechnologies Ltd. posted a movement of +104.21% for the period of last 100 days, recording 38,678 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CLGN is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of CollPlant Biotechnologies Ltd. (CLGN)
Raw Stochastic average of CollPlant Biotechnologies Ltd. in the period of last 50 days is set at 58.36%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 39.62%. In the last 20 days, the company’s Stochastic %K was 78.79% and its Stochastic %D was recorded 84.01%.
Considering, the past performance of CollPlant Biotechnologies Ltd., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 125.16%. Additionally, trading for the stock in the period of the last six months notably improved by 164.74%, alongside a boost of 119.26% for the period of the last 12 months. The shares increased approximately by 33.61% in the 7-day charts and went down by 85.40% in the period of the last 30 days. Common stock shares were driven by 258.73% during last recorded quarter.